Intervention
Arm 1
ClinicalTrials.gov intervention label
Clinical trials
5 shownCollection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain MetastasesNCT07619534 · 2026-10-12
RECRUITINGStem Cell Ophthalmology Treatment Study IINCT03011541 · 2016-01-01
RECRUITINGA Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung CancerNCT06620796 · 2024-09-30
NOT_YET_RECRUITINGBrighter Bites & UT Physicians Produce Rx ProgramNCT05556070 · 2022-10-17
COMPLETEDPatient-Centered Decision Support to Improve Diabetes Management in Pre-Teens and Adolescents With Type 1 DiabetesNCT03084900 · 2017-07-27
COMPLETEDCommon conditions
Age-Related Macular Degeneration1Blindness1Breast Cancer1Breast Carcinoma1Cancer of the Breast1Diabetes Mellitus1Glaucoma1Leber Hereditary Optic Neuropathy1Macular Degeneration1Maculopathy1Malignant Neoplasm of Breast1Nonarteritic Ischemic Optic Neuropathy1Obesity, Childhood1Optic Atrophy1Optic Nerve Disease1Optic Neuropathy1Retina Atrophy1Retinal Disease1Retinitis Pigmentosa1Retinopathy1SCLC, Extensive Stage1Stargardt Disease1Vision Loss Night1Vision Loss Partial1Vision, Low1
Leading sponsors
Trial status mix
COMPLETED2
RECRUITING2
NOT_YET_RECRUITING1
Phase mix
NA3
PHASE21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.